Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Effects of Alpha-Glucosidase Inhibiting Drugs on Acute Postprandial Glucose and Insulin Responses: a Systematic Review and Meta-Analysis

Alssema, Marjan
Ruijgrok, Carolien
Blaak, Ellen E.
Egli, Léonie
Dussort, Pierre
Vinoy, Sophie
Dekker, Jacqueline M.
Robertson, M. Denise

January 2020

Background/Objectives: Despite considerable literature supporting the potential health benefits of r...

Advances in GLP-1 treatment : focus on oral semaglutide

Eliaschewitz, Freddy Goldberg
Canani, Luis Henrique Santos

January 2021

Background: There is currently a large arsenal of antidiabetic drugs available to treat type 2 diabe...

OPEN ORIGINAL ARTICLE

August 2016

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetit...

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Galderisi, Alfonso
Sherr, Jennifer
Vanname, Michelle
Carria, Lori
Zgorski, Melinda
Tichy, Eileen
Weyman, Kate
Cengiz, Eda
Weinzimer, Stuart
Tamborlane, William

January 2018

Postprandial hyperglycemia remains a challenge in type 1 diabetes (T1D) due, in part, to dysregulate...

Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes

Hinshaw, Ling
Dadlani, Vikash
Mallad, Ashwini
Bharucha, Adil
Basu, Rita
Geske, Jennifer R.
Carter, Rickey E.
Basu, Ananda
Kudva, Yogish C.
SCHIAVON, MICHELE
DALLA MAN, CHIARA
COBELLI, CLAUDIO

January 2016

Context: Early postprandial hyperglycemia and delayed hypoglycemia remain major problems in current ...

Articles in PresS

February 2020

Abstract 18 Diabetes mellitus is a disease characterized by elevated blood glucose levels and repres...

ORIGINAL RESEARCH ARTICLE Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release

Aki Okamoto
Hirohide Yokokawa
Hironobu Sanada

January 2014

The Author(s) 2014. This article is published with open access at Springerlink.com Aim We aimed to e...

Postprandial hyperglycemia: a new frontier in diabetes management?

Ada Maffettone
Massimo Rinaldi
Andrea Fontanella

June 2018

Postprandial hyperglycemia is one of the earliest abnormalities of glucose homeostasis associated wi...

ORIGINAL RESEARCH ARTICLE Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data

Kazuki Murai
Tomoyuki Katsuno
Jun-ichiro Miyagawa
Toshihiro Matsuo
Fumihiro Ochi
Masaru Tokuda
Yoshiki Kusunoki
Masayuki Miuchi
Mitsuyoshi Namba

January 2014

The Author(s) 2014. This article is published with open access at Springerlink.com Background Sitagl...

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials

Kathrin Herrmann (26441)
Steven C. Brunell (5326199)
Yan Li (23143)
Ming Zhou (73279)
David G. Maggs (5326196)

June 2018

Article full text The full text of this article can be found here....

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

Gerich J

December 2013

John Gerich Department of Medicine, Endocrine/Metabolism Division, University of Rochester School of...

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.

Laar, F.A. van de
Lucassen, P.L.B.J.
Akkermans, R.P.
Lisdonk, E.H. van de
Grauw, W.J.C. de

January 2006

Contains fulltext : 50590.pdf (publisher's version ) (Open Access)BACKGROUND: Alph...

Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes

John Pullman
Tamara Darsow
Juan P Frias

September 2006

John Pullman1, Tamara Darsow2, Juan P Frias21Mercury Street Medical Group, Butte, MT, USA; 2Amylin P...

Original Research Article To Compare the Effect of Oral Hypoglycaemic Drugs Glibenclamide and Pioglitazone on Blood Sugar, Lipid Abnormalities in Type 2 Diabetes Mellitus

Vitthal S. Shinde
M. G. Kalekar
B. D. Samant
D. R. Chaudhari
Vijay P. More
Rasika D. Yadav

October 2015

Type 2 diabetes mellitus is often characterized by hyperglycemia as a result of increased insulin re...

Published by:

February 2015

achieving best practice It is estimated that 39 % of diabetic patients worldwide that use insulin th...

Effects of Alpha-Glucosidase Inhibiting Drugs on Acute Postprandial Glucose and Insulin Responses: a Systematic Review and Meta-Analysis

Alssema, Marjan
Ruijgrok, Carolien
Blaak, Ellen E.
Egli, Léonie
Dussort, Pierre
Vinoy, Sophie
Dekker, Jacqueline M.
Robertson, M. Denise

January 2020

Background/Objectives: Despite considerable literature supporting the potential health benefits of r...

Advances in GLP-1 treatment : focus on oral semaglutide

Eliaschewitz, Freddy Goldberg
Canani, Luis Henrique Santos

January 2021

Background: There is currently a large arsenal of antidiabetic drugs available to treat type 2 diabe...

OPEN ORIGINAL ARTICLE

August 2016

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetit...

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Galderisi, Alfonso
Sherr, Jennifer
Vanname, Michelle
Carria, Lori
Zgorski, Melinda
Tichy, Eileen
Weyman, Kate
Cengiz, Eda
Weinzimer, Stuart
Tamborlane, William

January 2018

Postprandial hyperglycemia remains a challenge in type 1 diabetes (T1D) due, in part, to dysregulate...

Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes

Hinshaw, Ling
Dadlani, Vikash
Mallad, Ashwini
Bharucha, Adil
Basu, Rita
Geske, Jennifer R.
Carter, Rickey E.
Basu, Ananda
Kudva, Yogish C.
SCHIAVON, MICHELE
DALLA MAN, CHIARA
COBELLI, CLAUDIO

January 2016

Context: Early postprandial hyperglycemia and delayed hypoglycemia remain major problems in current ...

Articles in PresS

February 2020

Abstract 18 Diabetes mellitus is a disease characterized by elevated blood glucose levels and repres...

ORIGINAL RESEARCH ARTICLE Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release

Aki Okamoto
Hirohide Yokokawa
Hironobu Sanada

January 2014

The Author(s) 2014. This article is published with open access at Springerlink.com Aim We aimed to e...

Postprandial hyperglycemia: a new frontier in diabetes management?

Ada Maffettone
Massimo Rinaldi
Andrea Fontanella

June 2018

Postprandial hyperglycemia is one of the earliest abnormalities of glucose homeostasis associated wi...

ORIGINAL RESEARCH ARTICLE Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data

Kazuki Murai
Tomoyuki Katsuno
Jun-ichiro Miyagawa
Toshihiro Matsuo
Fumihiro Ochi
Masaru Tokuda
Yoshiki Kusunoki
Masayuki Miuchi
Mitsuyoshi Namba

January 2014

The Author(s) 2014. This article is published with open access at Springerlink.com Background Sitagl...

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials

Kathrin Herrmann (26441)
Steven C. Brunell (5326199)
Yan Li (23143)
Ming Zhou (73279)
David G. Maggs (5326196)

June 2018

Article full text The full text of this article can be found here....

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

Gerich J

December 2013

John Gerich Department of Medicine, Endocrine/Metabolism Division, University of Rochester School of...

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.

Laar, F.A. van de
Lucassen, P.L.B.J.
Akkermans, R.P.
Lisdonk, E.H. van de
Grauw, W.J.C. de

January 2006

Contains fulltext : 50590.pdf (publisher's version ) (Open Access)BACKGROUND: Alph...

Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes

John Pullman
Tamara Darsow
Juan P Frias

September 2006

John Pullman1, Tamara Darsow2, Juan P Frias21Mercury Street Medical Group, Butte, MT, USA; 2Amylin P...

Original Research Article To Compare the Effect of Oral Hypoglycaemic Drugs Glibenclamide and Pioglitazone on Blood Sugar, Lipid Abnormalities in Type 2 Diabetes Mellitus

Vitthal S. Shinde
M. G. Kalekar
B. D. Samant
D. R. Chaudhari
Vijay P. More
Rasika D. Yadav

October 2015

Type 2 diabetes mellitus is often characterized by hyperglycemia as a result of increased insulin re...

Published by:

February 2015

achieving best practice It is estimated that 39 % of diabetic patients worldwide that use insulin th...

Effects of Alpha-Glucosidase Inhibiting Drugs on Acute Postprandial Glucose and Insulin Responses: a Systematic Review and Meta-Analysis

Alssema, Marjan
Ruijgrok, Carolien
Blaak, Ellen E.
Egli, Léonie
Dussort, Pierre
Vinoy, Sophie
Dekker, Jacqueline M.
Robertson, M. Denise

January 2020

Background/Objectives: Despite considerable literature supporting the potential health benefits of r...

Advances in GLP-1 treatment : focus on oral semaglutide

Eliaschewitz, Freddy Goldberg
Canani, Luis Henrique Santos

January 2021

Background: There is currently a large arsenal of antidiabetic drugs available to treat type 2 diabe...

OPEN ORIGINAL ARTICLE

August 2016

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetit...

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Abstract

Extracted data

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Abstract

Extracted data

Related items

Related items